Search research articles
Contact Us
Filters
Showing results (111-120 of 868) with videos related to
Page
of 87
Sort By:
International Journal of Hematology
|
April 22, 2016
Histone deacetylase inhibitors in multiple myeloma: from bench to bedside
Takeshi Harada, Teru Hideshima, Kenneth C Anderson
British Journal of Haematology
|
December 21, 2002
Novel therapies for multiple myeloma
Toshiaki Hayashi, Teru Hideshima, Kenneth C Anderson
Leukemia & Lymphoma
|
December 16, 2006
Non-steroidal anti-inflammatory drug therapy for chronic lymphocytic leukemia
Hiroshi Yasui, Teru Hideshima, Kenneth C Anderson
BMC Biochemistry
|
November 26, 2008
Targeting the UPS as therapy in multiple myeloma
Dharminder Chauhan, Giada Bianchi, Kenneth C Anderson
Blood Cancer Journal
|
September 8, 2018
The biological significance of histone modifiers in multiple myeloma: clinical applications
Hiroto Ohguchi, Teru Hideshima, Kenneth C Anderson
Expert Review of Precision Medicine and Drug Development
|
August 20, 2021
Proteomics-inspired precision medicine for treating and understanding multiple myeloma
Matthew Ho, Giada Bianchi, Kenneth C Anderson
Leukemia & Lymphoma
|
August 28, 2010
Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients
Meghan Rourke, Kenneth C Anderson, Irene M Ghobrial
Blood
|
June 3, 2015
Promising therapies in multiple myeloma
Giada Bianchi, Paul G Richardson, Kenneth C Anderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2005
Development of effective new treatments for multiple myeloma
Kenneth C Anderson, Richard Pazdur, Ann T Farrell
Journal of Oncology Practice
|
November 29, 2017
Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
Charles A Schiffer, Kari Bohlke, Kenneth C Anderson
Page
of 87
Search research articles
Search
Showing results (111-120 of 868) with videos related to
Sort By:
Page
of 87
International Journal of Hematology
|
April 22, 2016
Histone deacetylase inhibitors in multiple myeloma: from bench to bedside
Takeshi Harada, Teru Hideshima, Kenneth C Anderson
British Journal of Haematology
|
December 21, 2002
Novel therapies for multiple myeloma
Toshiaki Hayashi, Teru Hideshima, Kenneth C Anderson
Leukemia & Lymphoma
|
December 16, 2006
Non-steroidal anti-inflammatory drug therapy for chronic lymphocytic leukemia
Hiroshi Yasui, Teru Hideshima, Kenneth C Anderson
BMC Biochemistry
|
November 26, 2008
Targeting the UPS as therapy in multiple myeloma
Dharminder Chauhan, Giada Bianchi, Kenneth C Anderson
Blood Cancer Journal
|
September 8, 2018
The biological significance of histone modifiers in multiple myeloma: clinical applications
Hiroto Ohguchi, Teru Hideshima, Kenneth C Anderson
Expert Review of Precision Medicine and Drug Development
|
August 20, 2021
Proteomics-inspired precision medicine for treating and understanding multiple myeloma
Matthew Ho, Giada Bianchi, Kenneth C Anderson
Leukemia & Lymphoma
|
August 28, 2010
Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients
Meghan Rourke, Kenneth C Anderson, Irene M Ghobrial
Blood
|
June 3, 2015
Promising therapies in multiple myeloma
Giada Bianchi, Paul G Richardson, Kenneth C Anderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2005
Development of effective new treatments for multiple myeloma
Kenneth C Anderson, Richard Pazdur, Ann T Farrell
Journal of Oncology Practice
|
November 29, 2017
Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
Charles A Schiffer, Kari Bohlke, Kenneth C Anderson
Page
of 87